Agex Therapeutics Stock EBITDA
| AGEDelisted Stock | USD 0.74 0.01 1.37% |
AgeX Therapeutics fundamentals help investors to digest information that contributes to AgeX Therapeutics' financial success or failures. It also enables traders to predict the movement of AgeX Stock. The fundamental analysis module provides a way to measure AgeX Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AgeX Therapeutics stock.
AgeX |
AgeX Therapeutics Company EBITDA Analysis
AgeX Therapeutics' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AgeX Therapeutics EBITDA | (9.83 M) |
Most of AgeX Therapeutics' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AgeX Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, AgeX Therapeutics reported earnings before interest,tax, depreciation and amortization of (9.83 Million). This is 101.12% lower than that of the Biotechnology sector and 109.81% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.25% higher than that of the company.
AgeX EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AgeX Therapeutics' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AgeX Therapeutics could also be used in its relative valuation, which is a method of valuing AgeX Therapeutics by comparing valuation metrics of similar companies.AgeX Therapeutics is currently under evaluation in ebitda category among its peers.
AgeX Fundamentals
| Return On Asset | -0.82 | |||
| Operating Margin | (63.57) % | |||
| Current Valuation | 33.33 M | |||
| Shares Outstanding | 2.5 M | |||
| Shares Owned By Insiders | 75.73 % | |||
| Shares Owned By Institutions | 5.64 % | |||
| Number Of Shares Shorted | 4.47 K | |||
| Price To Earning | (5.95) X | |||
| Price To Book | 12.96 X | |||
| Price To Sales | 221.90 X | |||
| Revenue | 142 K | |||
| Gross Profit | 125 K | |||
| EBITDA | (9.83 M) | |||
| Net Income | (14.8 M) | |||
| Cash And Equivalents | 645 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 4.37 M | |||
| Debt To Equity | 0.75 % | |||
| Current Ratio | 0.19 X | |||
| Book Value Per Share | 5.07 X | |||
| Cash Flow From Operations | (7.8 M) | |||
| Short Ratio | 3.88 X | |||
| Earnings Per Share | (13.36) X | |||
| Beta | 1.19 | |||
| Market Capitalization | 31.51 M | |||
| Total Asset | 11.96 M | |||
| Retained Earnings | (131.01 M) | |||
| Working Capital | (5.16 M) | |||
| Current Asset | 5.06 M | |||
| Current Liabilities | 5.17 M | |||
| Z Score | -14.21 | |||
| Net Asset | 11.96 M |
About AgeX Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AgeX Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AgeX Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AgeX Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in AgeX Stock
If you are still planning to invest in AgeX Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AgeX Therapeutics' history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |